1. Development of AVID200, a novel TGF-β targeting immunotherapy: Characterization of immunomodulatory effects. (December 2016) Authors: O'Connor-McCourt, M.; Lenferink, A.; Zwaagstra, J.; Sulea, T.; Weeratna, R.; Maleki, S.; Baardsnes, J.; Collins, C.; Cantin, C.; Durocher, Y.; Singh, R.; Figueredo, R.; Krishnan, L.; Koropatnick, J.; Tikhomirov, I. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗